healio.com
VIDEO: Copay, patient access programs can help combat costs for patients with Crohn’s
High medication costs and insurance rules can change what treatments a person with Crohn’s can actually get. Knowing about copay assistance and patient-access programs can lower or eliminate out-of-pocket cost and help maintain access if insurance changes.
Adults with Crohn’s disease, caregivers, clinicians who prescribe IBD treatments, and patients on biologic or infusion therapies concerned about drug costs or insurance coverage.
What To Know
What to know This Healio video transcript discusses how copay assistance programs and patient-access foundations from drug manufacturers can reduce out-of-pocket costs or provide free medication for eligible people with Crohn’s disease.
The speaker emphasizes that prior authorization and insurance coverage differences (for example, infusion drugs billed under hospital benefits vs. medications billed under pharmacy benefits) can affect which treatment routes are easier for a patient to access.
The speaker encourages prescribers to inform patients about copay programs and manufacturer-sponsored access foundations, and to consider coverage logistics (infusion vs. injection/pill) when choosing a therapy, since cost and insurance rules sometimes influence treatment decisions.
The clip is a brief expert perspective rather than new clinical research or formal guidelines. It aims to raise awareness about existing financial-assistance options and practical insurance-related considerations for treatment access.
This is an expert commentary (video transcript) not a clinical study. Programs and eligibility vary by manufacturer and by country; patients should contact their clinician, specialty pharmacy, or manufacturer assistance program for specific enrollment and eligibility details. The speaker discloses a relationship with AbbVie.
